Condividi
Home > Catalogo > Specifici per LEI > Menopause Support *HEF

Menopause Support *HEF

Menopause Support *HEF
120 caps. (650mg)
29.90€
Opinioni dei Clienti (0)




 
Menopause Support è una miscela di 10 piante della foresta pluviale che sono state utilizzate dalla medicina popolare per i sintomi associati alla menopausa.

Che cosa significa "HEF"? Per scoprirlo, clicca qui.

Perchè acquistare Menopause Support? Per saperne di più clicca qui




Ingredienti: 100% pura miscela di maca, suma, cumaseba, espinheira santa, black cohosh, chuchuhuasi, sarsaparilla, muira puama, damiana, e passionflower.

Uso suggerito: Come integratore alimentare. Assumere 2-3 capsule 2 volte al giorno oppure al bisogno.

Controindicazioni:
  • Non usare durante la gravidanza o l'allattamento.
  • Non usare nei casi di tumori estrogeno-positivi.

Interazioni con farmaci: Nessuna segnalata; tuttavia, potrebbe potenziare i farmaci per abbassare la pressione.

Altre osservazioni pratiche:
  • É stato documentato che numerose piante contenute in questa miscela possono ridurre la pressione arteriosa. Chi soffre di bassa pressione dovrebbe monitorarsi per questo possibile effetto.
  • Sarsaparilla potrebbe influenzare la velocità di espulsione dal fegato di alcuni farmaci. Si ritiene inoltre che questa pianta potrebbe aumentare l'assorbimento della digitale e potenziare la velocità di eliminazione degli ipnotici. Pertanto, coloro che assumono questi farmaci dovrebbero monitorarsi per questi possibili effetti.

Chi ha acquistato Menopause Support, ha richiesto anche:
  • Natural Progesterone, crema per il corpo a base di progesterone naturale
  • 7-Keto DHEA, crema corpo dalle proprietà anti-ossidanti
  • Estriol Care, crema corpo a base di estriolo naturale
  • Maca, erba della foresta amazzonica impiegata dagli indigeni nei casi di disturbi della fertilità, irregolarità mestruali e squilibri ormonali
  • Clavo Huasca, la più famosa pianta del Perù per il potenziamento della libido maschile e femminile





Bibliografia

Maca (Lepidium meyenii)
Ruiz-Luna, A.C., et al. “Lepidium meyenii (Maca) increases litter size in normal adult female mice.” Reprod. Biol. Endocrinol. 2005 May; 3(1): 16.
Lopez-Fando, A., et al. “Lepidium peruvianum Chacon restores homeostasis impaired by restraint stress.” Phytother. Res. 2004; 18(6): 471-4.
Zheng, B. L., et al. “Effect of a lipidic extract from Lepidium meyenii on sexual behavior in mice and rats." Urology 2000; 55(4): 598–602.
Bogani, P., et al. “Lepidium meyenii (Maca) does not exert direct androgenic activities.” J. Ethnopharmacol. 2005 Oct 17;

Suma (Pfaffia paniculata)
Oshima, M., et al. “Pfaffia paniculata-induced changes in plasma estradiol-17beta, progesterone and testosterone levels in mice.” J. Reprod. Dev. 2003 Apr; 49(2): 175-80.
Arletti, R., et al. “Stimulating property of Turnera diffusa and Pfaffia paniculata extracts on the sexual behavior of male rats." Psychopharmacology. 1999; 143(1): 15–9.
Pinello, K.C., et al. “Effects of Pfaffia paniculata (Brazilian ginseng) extract on macrophage activity.” Life Sci. 2005 Oct 6;

Cumaseba (Swartzia polyphylla)
Moon, Y. J., et al. "Effects of flavonoids genistein and biochanin a on gene expression and their metabolism in human mammary cells." Nutr. Cancer. 2007; 57(1): 48-58.
Moon, Y. J.,et al. "Pharmacokinetics and bioavailability of the isoflavone biochanin A in rats." AAPS. J. 2006 July; 8(3): E433-42.
Schrepfer, S., et al. "The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity." Menopause. 2006 May-Jun; 13(3): 489-99.
Linseisen J, et al. "Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study." Int. J. Cancer. 2004 Jun 10;110(2):284-90.

Espinheira Santa (Maytenus ilicifolia)
Montanari, T., et al. “Effect of Maytenus ilicifolia Mart. on pregnant mice." Contraception. 2002 Feb; 65(2): 171–75.
Montanari, T., et al. “Effect of Maytenus ilicifolia Mart. Ex. Reiss on spermatogenesis." Contraception. 1998; 57(5): 335–39.
Bingel, A. S., et al. “Antifertility screening of selected plants in female rats.” Lloydia. 1976: 39(6): 475C.

Black Cohosh (Cimicifuga racemosa)
American Academy of Family Physicians. “Information from your family doctor. Nonhormonal options for hot flashes.” Am. Fam. Physician. 2006 Feb; 73(3): 467.
Carroll, D. G. “Nonhormonal therapies for hot flashes in menopause.” Am. Fam. Physician. 2006 Feb; 73(3): 457-64.
Uebelhack, R., et al. “Black cohosh and St. John's wort for climacteric complaints: a randomized trial.” Obstet. Gynecol. 2006 Feb; 107(2 Pt 1): 247-55.
Frei-Kleiner, S., et al. “Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.” Maturitas. 2005 Aug; 51(4): 397-404.
Nappi, R. E., et al. “Efficacy of Cimicifuga racemosa on climacteric complaints: a randomized study versus low-dose transdermal estradiol.” Gynecol. Endocrinol. 2005; 20(1): 30-5.
McKee, J., et al. “Integrative therapies for menopause.” South Med. J. 2005; 98(3): 319-26.
Pockaj, B.A., et al. “Pilot evaluation of black cohosh for the treatment of hot flashes in women.” Cancer Invest. 2004; 22(4): 515-21.
Lieberman, S. “A review of the effectiveness of Cimicifuga racemosa (black cohosh) for the symptoms of menopause.” J. Women’s Health. 1998; 7(5): 525-9.
Dog, T. L., et al. “Critical evaluation of the safety of Cimicifuga racemosa in menopause symptom relief.” Menopause. 2003; 10(4): 299-313.
Hernandez Munoz, G., et al. “Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer.” Maturitas. 2003; 44 Suppl 1:S59-65.
Winterhoff, H., et al. “Cimicifuga extract BNO 1055: reduction of hot flushes and hints on antidepressant activity.” Maturitas. 2003; 44 Suppl 1:S51-8.
Mahady, G. B., et al. “Black cohosh: an alternative therapy for menopause?” Nutr. Clin. Care. 2002; 5(6):283-9.

Chuchuhuasi (Maytenus krukovii)
Honda, T., et al. “Partial synthesis of krukovines A and B, triterpene ketones isolated from the Brazilian medicinal plant Maytenus krukovii.” J. Nat. Prod. 1997; 60(11): 1174-77.
Morita, H., et al. “Triterpenes from Brazilian medicinal plant “chuchuhuasi” (Maytenus krukovii).” J. Nat. Prod. 1996; 59(11): 1072-75.
Sekar K. V., et al. “Mayteine and 6-benzoyl-6-deacetyl-mayteine from Maytenus krukovii.” Planta Med. 1995; 61: 390.
Bradshaw, D., et al. “Therapeutic potential of protein kinase C inhibitors.” Agents and Actions 1993; 38: 135-47.

Sarsaparilla (Smilax officinalis)
Chu, K. T., et al. “Smilaxin, a novel protein with immunostimulatory, antiproliferative, and HIV-1-reverse transcriptase inhibitory activities from fresh Smilax glabra rhizomes.” Biochem. Biophys. Res. Commun. 2005 Dec; 340(1): 118.
Hu Y, et al. “A new approach to the pharmacological regulation of memory: Sarsasapogenin improves memory by elevating the low muscarinic acetylcholine receptor density in brains of memory-deficit rat models.” Brain Res. 2005 Oct; 1060(1-2): 26-39.
Jiang, J., et al. “Immunomodulatory activity of the aqueous extract from rhizome of Smilax glabra in the later phase of adjuvant-induced arthritis in rats." J. Ethnopharmacol. 2003; 85(1): 53–9.

Muira puama (Ptychopetalum olacoides)
Waynberg, J., et al. “Effects of Herbal vX on libido and sexual activity in premenopausal and postmenopausal women.” Adv. Ther. 2000; 17(5): 255-62.
da Silva, A. L., et al. “Memory retrieval improvement by Ptychopetalum olacoides in young and aging mice.” J. Ethnopharmacol. 2004 Dec; 95(2-3): 199-203.
da Silva, A. L., et al. “Anxiogenic properties of Ptychopetalum olacoides Benth. (Marapuama).” Phytother. Res. 2002; 16(3): 223-6.
Siqueira, I. R., et al. “Psychopharamcological properties of Ptychopetalum olachoides Bentham (Olacaceae).” Pharmaceutical Biol. 1998; 36(5): 327–34.
Paiva, L., et al. "Effects of Ptychopetalum olacoides extract on mouse behaviour in forced swimming and open field tests." Phytother. Res. 1998; 12(4): 294-96.

Damiana (Turnera aphrodisiaca)
Zava, D. T., et al. “Estrogen and progestin bioactivity of foods, herbs and spices.” Proc. Soc. Exp. Biol. Med. 1998; 217(3): 369–78.
Rowland, D. L., et al. “A review of plant-derived and herbal approaches to the treatment of sexual dysfunctions.” J. Sex Marital Ther. 2003 May-Jun; 29(3): 185-205.
Arletti, R., et al. “Stimulating property of Turnera diffusa and Pfaffia paniculata extracts on the sexual-behavior of male rats." Psychopharmacology. 1999; 143(1): 15–19.
Kumar, S., et al. “Anti-anxiety activity studies on homoeopathic formulations of Turnera aphrodisiaca Ward.” Evid. Based Complement. Alternat. Med. 2005 Mar; 2(1): 117-119.

Passionflower (Passiflora incarnata)
Wheatley, D. “Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability.” J. Psychopharmacol. 2005 Jul; 19(4): 414-21.
Shinomiya, K., et al. “Hypnotic activities of chamomile and passiflora extracts in sleep-disturbed rats.” Biol. Pharm. Bull. 2005; 28(5): 808-10.
Dhawan, K., et al. “Attenuation of benzodiazepine dependence in mice by a tri-substituted benzoflavone moiety of Passiflora incarnata Linneaus: a non-habit forming anxiolytic.” J. Pharm. Pharm. Sci. 2003 May-Aug; 6(2): 215-22.
Dhawan, K., et al. “Comparative anxiolytic activity profile of various preparations of Passiflora incarnata Linneaus: a comment on medicinal plant’s standardization.” J. Altern. Complement. Med. 2002; 8(3): 283-91.
Dhawan, K., et al. “Suppression of alcohol-cessation-oriented hyper-anxiety by the benzoflavone moiety of Passiflora incarnata Linneaus in mice.” J. Ethnopharmacol. 2002; 81(2): 239-44.
Dhawan, K., et al. “Anxiolytic activity of aerial and underground parts of Passiflora incarnata.” Fitoterapia. 2001; 72(8): 922-6.
Akhondzadeh, S., et al. “Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam.” J. Clin. Pharm. Ther. 2001; 26(5): 363-7.








AVVERTENZA: Le informazioni fornite in queste pagine hanno solo scopo informativo e sono tratte da pubblicazioni internazionali. Le proprietà naturali delle erbe sono unicamente da riferire alle comuni utilizzazioni nella tradizione popolare ed erboristica. I nostri prodotti non si propongono di diagnosticare, trattare, curare o prevenire alcuna malattia. Non si intende fornire suggerimenti per diagnosi o trattamenti di malattie. In caso di necessità consultare un medico.